Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / In brief: Erenumab (Aimovig) hypersensitivity.

< BACK TO ARCHIVE


2019 Mar 25


Med Lett Drugs Ther


http://www.ncbi.nlm.nih.gov/pubmed/31022159?dopt=Abstract


61


1568

In brief: Erenumab (Aimovig) hypersensitivity.

Authors

In brief: Erenumab (Aimovig) hypersensitivity.
Med Lett Drugs Ther. 2019 Mar 25; 61(1568):48.
PMID: 31022159.